Bal Pharma Ltd.
BSE: 524824 | Sector: Health care |
NSE: BALPHARMA | ISIN Code: INE083D01012 |
BSE 00:00 | 06 Jul | 91.50 |
-3.40 (-3.58%) |
OPEN
95.55 |
HIGH
95.75 |
LOW
90.55 |
NSE 00:00 | 06 Jul | 92.70 |
-2.05 (-2.16%) |
OPEN
94.70 |
HIGH
97.25 |
LOW
91.35 |
OPEN | 95.55 |
PREVIOUS CLOSE | 94.90 |
VOLUME | 4321 |
52-Week high | 148.50 |
52-Week low | 87.50 |
P/E | 16.61 |
Mkt Cap.(Rs cr) | 142 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Bal Pharma Ltd. (BALPHARMA) - Cash Flow
Figures in Rs crore | 2021 | 2020 | 2019 |
Opening Cash & Cash Equivalents | 0.68 | 2.20 | 2.58 |
Net Cash From Operating Activities | 10.24 | 21.71 | 11.55 |
Net Cash Used In/from Investing Activities | -6.66 | -3.30 | -11.98 |
Net Cash Used In/from Financing Activities | -3.36 | -19.94 | 0.05 |
Net (decrease)/increase In Cash and Cash Equivalents |
0.21 | -1.52 | -0.38 |
Closing Cash & Cash Equivalents | 0.89 | 0.68 | 2.20 |
Quick Links for Bal Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices